Arkolith/Insider Trading/CHE/Form 4

Wherley Joel L

CEO - Vitas HealthcareCHEMED CORP (CHE) · full profile →Form 4 · filed Feb 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 13, 2026Tax withholding(F)80$469.56$38K852
Feb 13, 2026Option exercise(M)273$469.56$128K932
Feb 13, 2026Option exercise(M)0$469.56$0932

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 13, 2026Option exercise(M)220—$01K
Feb 13, 2026Option exercise(M)220—$01K
Feb 13, 2026Grant(A)1K—$02K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-054514) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML